Aaron G.l. Fletcher has bought stock on 12 days since May 2020
Director and 10% owner at Actuate Therapeutics, Inc. Common stock, and 6 other companies
SEC CIK 0001789490 · Filings on SEC.gov ↗
Aaron G.l. Fletcher's record
3 months after each buy, from the first price a copier could get.
7 buys since 2020 with 3 months of prices.
Companies
Every filing
19 filings since May 2020, newest first
Actuate Therapeutics, Inc.
Director and 10% owner
Actuate Therapeutics, Inc.
Director and 10% owner
Lantern Pharma Inc.
10% owner
Lantern Pharma Inc.
10% owner
Lantern Pharma Inc.
10% owner
Lantern Pharma Inc.
10% owner
Azitra Inc
10% owner
In8Bio, Inc.
Director and 10% owner
Lantern Pharma Inc.
10% owner
Lantern Pharma Inc.
10% owner
In8Bio, Inc.
Director and 10% owner
In8Bio, Inc.
Director and 10% owner
In8Bio, Inc.
Director and 10% owner
Tff Pharmaceuticals, Inc.
Director
Cue Biopharma, Inc.
Director
Tff Pharmaceuticals, Inc.
Director
Cognition Therapeutics Inc
Director
Tff Pharmaceuticals, Inc.
Director
Tff Pharmaceuticals, Inc.
Director
Filings come from SEC EDGAR. Not investment advice.